Defining an IBD-like subgroup in consensus molecular subgroups of colorectal cancer and transcriptomic biomarker development for at-risk patients.

Research output: Contribution to journalMeeting abstract

Original languageEnglish
JournalJournal of Clinical Oncology : official journal of the American Society of Clinical Oncology
Volume37
Issue number15_suppl
DOIs
Publication statusEarly online date - 26 May 2019

Fingerprint

Tumor Biomarkers
Ulcerative Colitis
Colorectal Neoplasms
Cluster Analysis
Mutation
Survival Analysis
Computational Biology

Cite this

@article{13cb2da86fef4e05aec69aff6b9b1aae,
title = "Defining an IBD-like subgroup in consensus molecular subgroups of colorectal cancer and transcriptomic biomarker development for at-risk patients.",
author = "Enya Scanlon and Murphy, {Seamus J} and Kennedy, {Richard D} and Blayney, {Jaine K}",
year = "2019",
month = "5",
day = "26",
doi = "10.1200/JCO.2019.37.15_suppl.e15142",
language = "English",
volume = "37",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "15_suppl",

}

TY - JOUR

T1 - Defining an IBD-like subgroup in consensus molecular subgroups of colorectal cancer and transcriptomic biomarker development for at-risk patients.

AU - Scanlon, Enya

AU - Murphy, Seamus J

AU - Kennedy, Richard D

AU - Blayney, Jaine K

PY - 2019/5/26

Y1 - 2019/5/26

U2 - 10.1200/JCO.2019.37.15_suppl.e15142

DO - 10.1200/JCO.2019.37.15_suppl.e15142

M3 - Meeting abstract

VL - 37

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 15_suppl

ER -